Dolby Laboratories (DLB) Tops Q2 EPS by 24c, Offers Q3 Guidance

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.91, $0.24 better than the analyst estimate of $0.67. Revenue for the quarter came in at $319.6 million versus the consensus estimate of $294.29 million.

GUIDANCE:

Dolby Laboratories sees Q3 2021 EPS of $0.37-$0.52, versus the consensus of $0.63. Dolby Laboratories sees Q3 2021 revenue of $260-290 million, versus the consensus of $278 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained